The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette–Guérin vaccination in southern England and northern Malawi
Open Access
- 13 October 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 146 (3) , 390-399
- https://doi.org/10.1111/j.1365-2249.2006.03222.x
Abstract
We report a large study of the effect of BCG vaccination on the in vitro 6-day whole blood interferon-gamma (IFN-gamma) response to antigens from eight species of mycobacteria among schoolchildren in south-eastern England, where bacille Calmette-Guérin (BCG) vaccination is highly protective against pulmonary tuberculosis, and among young adults in northern Malawi, where BCG vaccination is not protective. In the UK children, BCG induced an appreciable increase in IFN-gamma response to antigens from most species of mycobacteria. The degree of change was linked to the relatedness of the species to Mycobacterium bovis BCG, and provides further evidence of the cross-reactivity of mycobacterial species in priming of the immune system. IFN-gamma responses to purified protein derivatives (PPDs) from M. tuberculosis and environmental mycobacteria were more prevalent in the Malawian than the UK group prior to vaccination; BCG vaccination increased the prevalence of responses to these PPDs in the UK group to a level similar to that in Malawi. There was no evidence that the vaccine-induced change in IFN-gamma response was dependent upon the magnitude of the initial response of the individual to environmental mycobacteria in the United Kingdom or in Malawi. These observations should assist the development and interpretation of human clinical trials of new vaccines against M. tuberculosis in areas of both low and high exposure to environmental mycobacteria.Keywords
This publication has 23 references indexed in Scilit:
- The success and failure of BCG — implications for a novel tuberculosis vaccineNature Reviews Microbiology, 2005
- Interferon-γ and skin test responses of schoolchildren in southeast England to purified protein derivatives fromMycobacterium tuberculosisand other species of mycobacteriaClinical and Experimental Immunology, 2003
- Exposure to Mycobacterium avium primes the immune system of calves for vaccination with Mycobacterium bovis BCGClinical and Experimental Immunology, 2002
- Failure of theMycobacterium bovisBCG Vaccine: Some Species of Environmental Mycobacteria Block Multiplication of BCG and Induction of Protective Immunity to TuberculosisInfection and Immunity, 2002
- Patterns and Implications of Naturally Acquired Immune Responses to Environmental and Tuberculous Mycobacterial Antigens in Northern MalawiThe Journal of Infectious Diseases, 2001
- Phylogeny of Rapidly Growing Members of the Genus MycobacteriumInternational Journal of Systematic and Evolutionary Microbiology, 1992
- Effectiveness of BCG vaccination in england and wales in 1983Tubercle, 1987
- Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes.The Journal of Experimental Medicine, 1986
- Infection with Mycobacterium avium-intracellulare and the Protective Effects of Bacille Calmette-GuerinThe Journal of Infectious Diseases, 1982
- BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.BMJ, 1977